Skip to main content
Ramon Diaz-Arrastia, MD, Neurology, Philadelphia, PA, Hospital of the University of Pennsylvania

RamonRDiaz-ArrastiaMD

Neurology Philadelphia, PA

Epilepsy, Neuroimaging, Neurodegenerative, Neurocritical Care

University of Pennsylvania Perelman School of Medicine

Dr. Diaz-Arrastia is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Diaz-Arrastia's full profile

Already have an account?

  • Office

    Penn Presbyterian Medical Center
    51 North 39th Street, Andrew Mutch Building, Room 409
    Philadelphia, PA 19104
    Phone+1 215-662-9732
  • Is this information wrong?

Education & Training

  • New York Presbyterian Hospital (Columbia Campus)
    New York Presbyterian Hospital (Columbia Campus)Residency, Neurology, 1989 - 1992
  • Beth Israel Deaconess Medical Center
    Beth Israel Deaconess Medical CenterInternship, Internal Medicine, 1988 - 1989
  • Baylor College of Medicine
    Baylor College of MedicineClass of 1988

Certifications & Licensure

  • PA State Medical License
    PA State Medical License 2016 - 2024
  • TX State Medical License
    TX State Medical License 1989 - 2024
  • NY State Medical License
    NY State Medical License 1990 - 1994
  • American Board of Psychiatry and Neurology Neurology

Awards, Honors, & Recognition

  • Super Doctor SuperDoctors.com

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Effect of Transcranial Low-Level Light Therapy vs Sham Therapy Among Patients with Moderate Traumatic Brain Injury  
    Ramon Diaz-Arrastia, MD, JAMA Network Open

Authored Content

  • Epilepsy as a Network Disorder (2): What Can We Learn from Other Network Disorders Such as Dementia and Schizophrenia, and What Are the Implications for Translational Research?☆October 2017

Press Mentions

  • Bright Prognosis for Brain Injury Biomarkers
    Bright Prognosis for Brain Injury BiomarkersNovember 20th, 2022
  • Early Blood Tests for Traumatic Brain Injury Can Accurately Predict Which Patients Are Likely to Die
    Early Blood Tests for Traumatic Brain Injury Can Accurately Predict Which Patients Are Likely to DieAugust 20th, 2022
  • BRAINBox Solutions Awarded $3.5 Million NIH SBIR Grant to Develop Geriatric Specific Multi-Modality Diagnostic and Prognostic Testing System for mTBI (Concussion)
    BRAINBox Solutions Awarded $3.5 Million NIH SBIR Grant to Develop Geriatric Specific Multi-Modality Diagnostic and Prognostic Testing System for mTBI (Concussion)March 21st, 2022
  • Join now to see all

Grant Support

  • Traumatic Brain Injury Clinical Trials NetworkEunice Kennedy Shriver National Institute Of Child Health &Human Development2003–2012
  • Phase II, Randomized Controlled Trial Of Brain Tissue Oxygen MonitoringNational Institute Of Neurological Disorders And Stroke2009–2010
  • Genetic Factors In Outcome From Traumatic Brain InjuryEunice Kennedy Shriver National Institute Of Child Health &Human Development2004–2008
  • Hyperhomocysteinemia In Alzheimer'S DiseaseNational Institute On Aging2001–2003
  • Candidate Genetic Polymorphisms/ Hiv-Associated DementiaNational Institute Of Mental Health2001–2002
  • Cpla2 And Neurodegenerative DiseaseNational Institute On Aging1999
  • Neuronal Phospholipase A2National Institute Of Neurological Disorders And Stroke1994–1998
  • Stress And The Neuropathology Of Alzheimers DiseaseNational Institute On Aging1997

Other Languages

  • Spanish

Hospital Affiliations